The Spinal Muscular Atrophy (SMA) Treatment market was valued at USD 4,623.46 Million in 2022 and is expected to reach USD 18,718.08 Million by 2030, growing at a CAGR of 19.1% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.